• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

V-Wave

The biggest medtech M&A moves of 2024

December 27, 2024 By Sean Whooley

In 2024, we saw another proactive year for some of the biggest names in medtech as they looked to bolster their ranks through acquisitions. Over the course of the year, the number of billion-dollar sales deals continued to climb, with some companies involved more than once. Analysts even suggested that, in 2025, there could be […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: Axonics, Baxter, BD, Boston Scientific, Carl Zeiss Meditec, Carlyle Group, Edwards Lifesciences, Johnson & Johnson, Johnson & Johnson MedTech, Owens & Minor, Rotech Healthcare, Shockwave Medical, Silk Road Medical, V-Wave

Johnson & Johnson to buy heart failure treatment maker V-Wave for up to $1.7B

August 20, 2024 By Sean Whooley

Johnson & Johnson announced today that it agreed to acquire interatrial shunt maker V-Wave for up to $1.7 billion. The medtech giant says the planned acquisition extends its position as a leader in addressing cardiovascular disease. V-Wave develops cardiovascular implant technology that specifically targets heart failure with reduced ejection fraction (HFrEF). The company designed its […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Featured, Implants, Mergers & Acquisitions, Structural Heart, Wall Street Beat Tagged With: Johnson & Johnson, Johnson & Johnson MedTech, nitinol, V-Wave

15 heart devices that could boost their manufacturers’ sales

May 22, 2020 By Nancy Crotti

Before the coronavirus pandemic hit, medtech companies large and small were making notable news with a number of innovative heart devices. Some of these same companies took a big hit to their bottom lines when the danger of spreading COVID-19 and using up precious personal protective equipment convinced hospitals to limit non-urgent procedures. Now hospitals […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Clinical Trials, Featured, Food & Drug Administration (FDA), Hospital Care, Implants, Regulatory/Compliance, Replacement Heart Valves, Stent Grafts, Stents, Structural Heart, Wall Street Beat Tagged With: Abbott, Aris CV, Cardiofocus, cardiovalve, CE Mark, CryoLife, endospan, FDA, Medtronic, Terumo Aortic, V-Wave

V-Wave lands CE Mark for heart-failure device

March 5, 2020 By Nancy Crotti

V-Wave announced today that its Ventura interatrial shunt system has received the CE Mark. The Caesarea, Israel-based company’s minimally invasive, implanted interatrial shunt is being evaluated in a global, randomized, controlled, double-blinded, 500-patient pivotal IDE trial called RELIEVE-HF. The study is enrolling advanced heart failure patients with preserved or reduced left ventricular ejection fraction who […]

Filed Under: Cardiovascular, Featured, Regulatory/Compliance Tagged With: CE Mark, V-Wave

V-Wave’s interatrial shunt lands another breakthrough nod from FDA

September 13, 2019 By Sean Whooley

V-Wave said yesterday that it won FDA breakthrough device designation for its interatrial shunt for pulmonary arterial hypertension, marking the second time in less than a month that the company has earned a breakthrough nod. The PAH shunt is designed to be placed in the heart through a catheter inserted via a vein in the […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Clinical Trials, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: FDA, V-Wave

V-Wave wins breakthrough nod for heart failure device

August 15, 2019 By Nancy Crotti

V-Wave said today that the FDA has granted breakthrough device designation for its interatrial shunt for heart failure (HF). The Caesarea, Israel-based company’s minimally invasive, implanted interatrial shunt is being evaluated in a global, randomized, controlled, double-blinded, 500-patient pivotal IDE trial called RELIEVE-HF. The study is enrolling advanced heart failure patients with preserved or reduced […]

Filed Under: Cardiac Implants, Featured, Food & Drug Administration (FDA), Implants, News Well, Regulatory/Compliance, Research & Development Tagged With: FDA, V-Wave

HydroCision names Tranchemontagne as CEO | Personnel Moves – March 12, 2019

March 12, 2019 By Fink Densford

HydroCision said early this month that it tapped former Smith & Nephew (NYSE:SNN) exec Alain Tranchemontagne as its new chief executive officer. Prior to joining Boston-based HydroCision, Tranchemontagne held a position as U.S. business commercial development senior VP at Smith & Nephew. Before joining Smith & Nephew, Tranchemontagne also held positions at Covidien in senior marketing roles […]

Filed Under: Business/Financial News Tagged With: Aethlon Medical Inc., camberspine, Humacyte, HydroCision Inc., Invictus Medical, IRRAS, Johnson and Johnson, MediWounds, qureai, Senseonics, Smith & Nephew, SynCardia, V-Wave, Virta Health

V-Wave launches pivotal interatrial shunt trial

October 3, 2018 By Fink Densford

V-Wave said today it launched a new trial of its minimally invasive interartrial shunt designed to treat patients with symptomatic heart failure. The new Relieve-HF trial aims to enroll 500 patients in a pivotal study of the device, which is designed for patients with NHYA Class III and ambulatory Class IV symptomatic heart failure, the Israel-based […]

Filed Under: Cardiovascular, Clinical Trials, Vascular Tagged With: V-Wave

V-Wave closes $70 million Series C

April 26, 2018 By Fink Densford

V-Wave said today it raised $70 million in a closed Series C round of financing, with funds slated to support the launch of a pivotal trial of its investigational interatrial shunt device designed for patients with advanced heart failure. The interatrial shunt is designed to be implanted trans-venously and placed in the atrial septum, the Israel-based company said. […]

Filed Under: Business/Financial News, Stents, Vascular, Wall Street Beat Tagged With: Edwards Lifesciences, Johnson and Johnson, V-Wave

V-Wave touts 1st-in-human for interatrial shunt

March 28, 2016 By Fink Densford

V-Wave today released results from the 1st-in-human implantation of its investigational interatrial shunt device designed for patients with advanced heart failure, touting a 100% success rate for implantation and no device-related adverse events. The interatrial shunt is designed to be implanted trans-venously and placed in the atrial septum, where a valve regulates left to right shunting of […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials Tagged With: V-Wave

J&J joins Edwards in $28m Series B for arterial shunt dev V-Wave

January 12, 2016 By Fink Densford

Johnson & Johnson (NYSE:JNJ) joined previous investor Edwards Lifesciences (NYSE:EW) in a $28 million Series B round to support heart failure treating interarterial shunt maker V-Wave, according to a press release posted yesterday. Other groups joining the round included newly-invested TriVentures, Pura Vida Investments and BioStar Ventures, with returning investors Pontifax and the BRM group. “With the […]

Filed Under: Blood Management, Business/Financial News, Cardiac Implants, Cardiovascular Tagged With: V-Wave

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy